Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer

Clinical trial NCT02085005 · WITHDRAWN

Trial details

NCT number: NCT02085005
Sponsor: Sanofi
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2014-03-01
Primary completion: 2016-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.